Can personalized information help dementia patients accept palliative care?

NCT ID NCT05942040

Completed Knowledge-focused Sponsor: Rutgers, The State University of New Jersey Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether giving doctors tailored information about the benefits of community-based palliative care helps more people with dementia and their families accept it. Researchers worked with 301 Medicare Advantage members who were eligible for palliative care. The goal was to see if this approach is practical and acceptable, not to cure or treat dementia.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Tailored Palliative Care Information
What this could lead to: If successful, this approach could improve how palliative care is offered to people with dementia, making it more acceptable and accessible.
What could go wrong: This is a small, completed pilot study focused on feasibility, not a large trial testing a treatment. Results may not apply to other populations or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALZHEIMER'S DISEASE AND RELATED DEMENTIAS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Alzheimer disease dementia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ALZHEIMER'S DISEASE AND RELATED DEMENTIAS

Contacts and locations

Locations

VNS Health

New York, New York, 10017, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.